Portfolio company
Ethyreal Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops monoclonal antibodies to treat Graves' disease and thyroid eye disease for patients with these autoimmune conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Yarrow Bioscience
This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.
Viridiantherapeutics
This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.
Tourmaline Bio
This biotechnology firm develops antibody therapeutics for patients with immune and inflammatory conditions, including atherosclerotic cardiovascular disease and thyroid eye disease.
Ollin Bio
This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
Vor Bio
This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.
Candid Therapeutics
This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.
